Weiguo Gao
- Endocrinology, Diabetes and Metabolism top 2%
- Epidemiology top 10%
- Molecular Biology
- Nephrology top 2%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Qing QiaoJaakko TuomilehtoLei ZhangRegzedmaa NyamdorjZengchang PangHairong NanFeng NingShaojie Wang
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers)Metabolism, Diabetes, and Cancer (10 papers)Liver Disease Diagnosis and Treatment (9 papers)
- Journals
- PLoS ONEDiabetes CareDiabetologia
In The Last Decade
Weiguo Gao
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 111
- Endocrinology, Diabetes and Metabolism 687
- Epidemiology 401
- Molecular Biology 252
- Nephrology 215
- Cardiology and Cardiovascular Medicine 186
Countries citing papers authored by Weiguo Gao
This map shows the geographic impact of Weiguo Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Gao more than expected).
Fields of papers citing papers by Weiguo Gao
This network shows the impact of papers produced by Weiguo Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Gao. The network helps show where Weiguo Gao may publish in the future.
Co-authorship network of co-authors of Weiguo Gao
This figure shows the co-authorship network connecting the top 25 collaborators of Weiguo Gao. A scholar is included among the top collaborators of Weiguo Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiguo Gao. Weiguo Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 24 | |
| 5 | 19 | |
| 6 | 14 | |
| 7 | 28 | |
| 8 | 13 | |
| 9 | 15 | |
| 10 | 14 | |
| 11 | 30 | |
| 12 | 12 | |
| 13 | 2 | |
| 14 | 95 | |
| 15 | 20 | |
| 16 | 31 | |
| 17 | 25 | |
| 18 | 274 | |
| 19 | 86 | |
| 20 | 97 |
About Weiguo Gao
Weiguo Gao is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Applied Microbiology and Biotechnology, having authored 47 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Metabolism, Diabetes, and Cancer (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (687 citations), Nephrology (215 citations) and Epidemiology (401 citations). Weiguo Gao has collaborated with scholars based in China, Finland and Sweden. Frequent co-authors include Qing Qiao, Jaakko Tuomilehto, Lei Zhang, Regzedmaa Nyamdorj, Zengchang Pang, Hairong Nan, Feng Ning, Qing Qiao, Shaojie Wang and Yuesheng Dong. Their work appears in journals such as PLoS ONE, Diabetes Care and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.